“Cost-Effectiveness Profile, Organizational Implications and Patient Preferences on the Use of Exogenous TSH Therapy (Thyrogen®) Vs. THW in Thyroid Residue Ablation in Italy”. Farmeconomia. Health economics and therapeutic pathways 17, no. 3 (October 7, 2016). Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/1264.